BIOREGULATOR PEPTIDE CLINICAL RESEARCH

Our clinical research focuses on the therapeutic potential of three key bioregulator peptides: Epitalon, Thymogen, and Ventfort. These studies, led by Dr. Vladimir Khavinson, explore how Epitalon can lengthen telomeres to promote cellular rejuvenation and anti-aging, how Thymogen enhances immune function post-chemotherapy by stimulating and repairing immune cells, and how Ventfort improves vascular health by normalizing vascular wall function and regulating cholesterol levels. These findings underscore the significant health benefits of bioregulator peptides in promoting longevity, immune resilience, and cardiovascular health. For more detailed information, visit the cited sources on NCBI and NIH.